Objective: This article reviews evidence-based psychiatric uses of gabapentin, along with associated risks. Method of Research: An extensive literature review was conducted, primarily of articles searchable in PubMed, relating to psychiatric uses, safety, and adverse effects of gabapentin. Results: Evidence supports gabapentin as a treatment for alcohol withdrawal and alcohol use disorder. There is sufficient evidence to consider gabapentin as a third-line treatment for social anxiety disorder and severe panic disorder. Evidence does not support the use of gabapentin for bipolar disorder, major depressive disorder (MDD), posttraumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), stimulant use disorder, or opioid withdrawal. ...
Introduction. Gabapentin has been extensively prescribed off-label for psychiatric indications, with...
The gabapentinoids, gabapentin, and pregabalin, target the α2δ subunits of voltage-gated calcium cha...
Gabapentin, a relatively new anti-epileptic drug (liED), is emerging as a therapeutic option JOr tre...
Objective: Gabapentin (GBP) is an anticonvulsant medication that is also used to treat restless legs...
Problem: Up to 2 million Americans suffer from alcohol withdrawal syndrome (AWS) each year. Alcoholi...
Gabapentin is widely used in the United States for a number of off-label indications, often as an al...
Gabapentin is an anticonvulsant approved for adjunc-tive treatment of refractory complex partial sei...
This review summarizes current evidence on the abuse and misuse of the gabapentinoids pregabalin and...
Background: with increasing awareness of lithium's limitations, several new anticonvulsants had been...
This article will review the epidemiology and pharmacology of gabapentinoids (gabapentin and pregaba...
Objective: The current meta-analysis synthesizes previous findings on the effect of gabapentin on al...
Gabriel C Quintero Florida State University – Republic of Panama, Clayton, Panama Abstract: Th...
The gabapentinoids gabapentin and pregabalin have been related to addiction citing pharmacovigilance...
The gabapentinoids, gabapentin and pregabalin, target the α2δ subunits of voltage-gated calcium chan...
Gabapentin, an anticonvulsant and analgesic for postherpetic neuralgia, has been thought to have no ...
Introduction. Gabapentin has been extensively prescribed off-label for psychiatric indications, with...
The gabapentinoids, gabapentin, and pregabalin, target the α2δ subunits of voltage-gated calcium cha...
Gabapentin, a relatively new anti-epileptic drug (liED), is emerging as a therapeutic option JOr tre...
Objective: Gabapentin (GBP) is an anticonvulsant medication that is also used to treat restless legs...
Problem: Up to 2 million Americans suffer from alcohol withdrawal syndrome (AWS) each year. Alcoholi...
Gabapentin is widely used in the United States for a number of off-label indications, often as an al...
Gabapentin is an anticonvulsant approved for adjunc-tive treatment of refractory complex partial sei...
This review summarizes current evidence on the abuse and misuse of the gabapentinoids pregabalin and...
Background: with increasing awareness of lithium's limitations, several new anticonvulsants had been...
This article will review the epidemiology and pharmacology of gabapentinoids (gabapentin and pregaba...
Objective: The current meta-analysis synthesizes previous findings on the effect of gabapentin on al...
Gabriel C Quintero Florida State University – Republic of Panama, Clayton, Panama Abstract: Th...
The gabapentinoids gabapentin and pregabalin have been related to addiction citing pharmacovigilance...
The gabapentinoids, gabapentin and pregabalin, target the α2δ subunits of voltage-gated calcium chan...
Gabapentin, an anticonvulsant and analgesic for postherpetic neuralgia, has been thought to have no ...
Introduction. Gabapentin has been extensively prescribed off-label for psychiatric indications, with...
The gabapentinoids, gabapentin, and pregabalin, target the α2δ subunits of voltage-gated calcium cha...
Gabapentin, a relatively new anti-epileptic drug (liED), is emerging as a therapeutic option JOr tre...